E-DRUG: IGFAM - Differential Pricing Discussion Paper
-----------------------------------------------------
Dear E-druggers,
DFID has extended the deadline for completing this survey to 5 December.
More views on this topic would be gratefully received.
IGFAM is the UK Industry Government Forum on Access to Medicines established to promote dialogue on how industry and government can work together to promote access to medicines in developing countries. More details on IGFAM are provided at http://www.dfid.gov.uk/Global-Issues/Emerging-policy/IGFAM
DFID, on behalf of IGFAM, commissioned Professor Prashant Yadav of MIT-Zaragoza to review current knowledge about differential pricing, its current prevalence and to suggest ways in which it might be encouraged in such a way as to enhance access to medicines in low and middle income developing countries.
IGFAM is interested to solicit the views of stakeholders and other interested parties on Professor Yadav's paper as a means of stimulating debate on the issue of differential pricing, and on policies which governments, donor organisations and industry could adopt to facilitate access to medicines to poor patients in developing countries.
The full paper and a summary are available at
http://www.dfid.gov.uk/Global-Issues/Emerging-policy/IGFAM/Policy-Issues-and-Discussion-Papers
We would therefore be very grateful if you could take a little time (less than fifteen minutes) to complete the survey at http://www.surveymonkey.com/s/W7XZBMF
Please feel free to add your own comments and suggestions in the space provided in the survey.
The deadline for completing the survey is now 5 December.
We will then publish a report based on the responses by the end of December.
Best wishes
Saul Walker (DFID)
Jon Pender (GSK)
Co-chairs of IGFAM
[Submitted by Charles Clift, former DFID employee, now independent consultant]